InspireMD, Inc. announced on December 12, 2024, that Craig Shore, its Chief Financial Officer, decided to retire from the company. Mr. Shore served as CFO for 15 years and will remain in his role until a successor is identified and appointed, assisting with a smooth transition.
CEO Marvin Slosman acknowledged Mr. Shore's tireless commitment to building InspireMD into a global leader in carotid interventions. The company has initiated a search to identify its next Chief Financial Officer.
This transition comes as InspireMD advances its priorities, including potential U.S. FDA approval for CGuard Prime in the first half of 2025 and a heightened focus on the investment community. The change in financial leadership is a notable development as the company prepares for significant commercial growth.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.